Combining and augmenting: Choosing the right therapies for treatment-resistant depression

Psychiatric Annals

Volumn 35, Issue 12, 2005, Pages 993-1000

  Zajecka, John ^a,b   Goldstein, Corey ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH NORTH SHORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 30544440053     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498- 1504.
2. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60(4):221-225.
3. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 1997;277(4):333-340.
4. Thase ME. Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence. CNS Spectr. 2004;9(11):808-16, 818-21.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders [text revision]. 4th ed. Washington, DC: American Psychiatric Publishing; 2000.
6. Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission. Psychol Med. 1995;25(6):1171-1180.
7. Zajecka JM, Goldstein C. Combining medications to achieve remission. In: Schwartz T, ed. Handbook of Treating Depression. In press.
8. Physician's Desk Reference 95th ed. Montvale, NJ: Thompson PDR; 2005.
9. Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf. 2003;2(3):233-247.
10. Sproule BA, Naranjo CA, Brenmer KE, Hassan PC. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence. Clin Pharmacokinet. 1997;33(6):454-471.
11. Frank E, Novick D, Kupfer DJ. Antidepressants and psychotherapy: a clinical research review. Dialogues Clin Neurosci. 2005;7(3):263-272.
12. Kennedy N, Paykel ES. Treatment and response in refractory depression: results from a specialist affective disorders service. J Affect Disord. 2004;81(1):49-53.
13. Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev. 2005;29(3):493-500.
14. Hollon SD, Jarrett RB, Nierenberg AA, et al. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry. 2005;66(4):455-468.
15. Rush AJ, Fava M, Wisniewski SR, et al.; STAR*D Investigators Group. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25(1):119-142.